Posts Tagged ‘OHSU Knight Cardiovascular Institute’

New resource for researchers: KCVI Epigenetics Consortium

OHSU researchers have established the Knight Cardiovascular Institute Epigenetics Consortium to foster research and education in epigenetics. This team of experts assists investigators with the analysis of epigenetic regulation by combining evolving technologies and high-throughput sequencing. Services offered include bisulfite sequencing for DNA methylation, ChIP-seq (histone marks or transcription factors), ATAC-seq, and RNA-seq. The epigenetic consortium supports projects from start to finish, including study design, assays, bioinformatic analyses, and help with interpretation of the results. … Read More

Grand opening of Center for Radiochemistry Research, Sept. 20

The OHSU Knight Cardiovascular Institute cordially invites you to attend the ribbon cutting of the Center for Radiochemistry Research, the newest research building on Marquam Hill since the Biomedical Research Building opened in 2005. The center will provide OHSU scientists with a new suite of powerful imaging tools and expertise, including new labs, a cyclotron for isotope generation, and advanced imaging technology for preclinical and clinical research. The the facility and its resources will give OHSU … Read More

Lecture: “OregonHeart: Developing a total artificial heart,” May 28

The Knight Cardiovascular Institute invites you to attend “OregonHeart: Developing a total artificial heart,” a lecture providing an overview of the KCVI’s new company aimed at developing a successful total artificial heart device to treat patients with end-stage heart failure. OregonHeart’s Chief Scientific Officer and renowned inventor of the Hemopump, Richard Wampler, will present, along with other company representatives and OHSU faculty collaborators. Thursday, May 28, 2015 5 to 6:30 p.m. Collaborative Life Sciences Building, … Read More

OHSU Stroke Conference registration deadline Feb. 28

The fourth annual OHSU Stroke Conference will take place this year on Saturday, Mar. 7, 2015, from 9 a.m. to 5:30 p.m. in the Collaborative Life Science Building (CLSB). This one-day annual conference brings together OHSU clinicians and scientists interested in stroke, cerebrovascular disease and traumatic brain injury to share their expertise, report on scientific progress, and discuss research collaborations. This year’s event is hosted by Nabil Alkayed, M.D., Ph.D., professor and vice chair, Anesthesiology … Read More

Leading DOHaD researcher to give Research Week keynote, May 8

Chittaranjan Yajnik, M.D., FRCP, an international expert in the field of developmental origins of disease, has been invited by the School of Medicine Research Roadmap and the Knight Cardiovascular Institute Center for Developmental Health’s David J.P. Barker Memorial Lecture Series to give a lecture during Research Week on Thursday, May 8, from 12 to 1 p.m. in the OHSU Auditorium. Dr. Yajnik will lead us in a conversation about the rapidly rising epidemic of diabetes and non-communicable … Read More

Researchers find gene mutation that may make heart cell regeneration possible

In a paper published March 4 in Nature Communications, coauthored by Lincoln Shenje, M.D., Ph.D, assistant professor at the OHSU Knight Cardiovascular Institute, researchers describe the first found gene mutation in humans that causes heart muscle cells to proliferate beyond birth. This mutation was discovered in a rare syndrome called ALMS1 that has been reported in less than 70 people in the past 50 years worldwide. According to Dr. Shenje and colleagues, this discovery goes … Read More

Fluidigm to present state-of-the-art single-cell genomics technology, Nov. 8

The Fluidigm Corporation will be presenting on their single-cell genomics technology; an overview of the field of single-cell genomics and examples of applications on Friday, November 8 from 10 to 11 a.m. in Mac Hall 3189. This technology is currently deployed in the lab of Dr. Lincoln Shenje of the Knight Cardiovascular Institute. This research capability is made possible by the generous donation from the Knight Family, and this is one of the numerous ways in … Read More

Knight Cardiovascular Institute planning includes discussion of research themes

Last week, Albert Starr, M.D., and Sanjiv Kaul, M.D., co-directors of the new OHSU Knight Cardiovascular Institute, published a letter to update the OHSU community on the progress of the institute. Included in this update is a discussion of potential “signature research themes” for the Knight Cardiovascular Institute. We encourage you to read the full letter in the School of Medicine Research Voice.

Introducing the OHSU Knight Cardiovascular Institute

In September we announced a historic $125 million gift from Phil and Penny Knight to establish a new cardiovascular institute at OHSU. This week, the institute was officially named the OHSU Knight Cardiovascular Institute. Under the leadership of Albert Starr, M.D. and Sanjiv Kaul, M.D., the institute will aim to be a world leader in translational cardiovascular research. This gift comes four years after the creation of the OHSU Knight Cancer Institute, which thanks to … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.